Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases.
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In inflammatory bowel disease (IBD), immune activation with increased circulating TNF-α is linked to the intensity of gastrointestinal symptoms and depression or anxiety. A central feature of depression is cognitive biases linked to negative attributions about self, the world and the future. We aimed to assess the effects of anti-TNFα therapy on the central processing of self-attribution biases and visceral afferent information in patients with Crohn's disease. METHODS: We examined 9 patients with Crohn's disease (age 26.1±10.6. yrs, 5 female, 5 ileocolonic, 2 colonic and 2 ileal disease) during chronic anti-TNFα therapy (5 adalimumab, 4 infliximab). Patients were studied twice in randomized order before and after anti-TNFα administration. On each occasion patients underwent functional magnetic resonance imaging (fMRI) of the brain during a test of implicit attribution biases regarding sickness/health and undertook a standardized nutrient challenge. RESULTS: Following anti-TNFα treatment, ratings of 'fullness' following nutrient challenge reduced compared to pre-treatment ratings (p<0.05). Reaction times revealed improved processing of self-related and positive health words, consistent with improved implicit sense of wellbeing that correlated with improvements in sensory function after treatment (r = 0.67, p<0.05). Treatment-associated improvements in implicit processing were mirrored by alterations of prefrontal, amygdala, posterior cingulate and visual regions. Between patients, the degree of functional amygdala change was additionally explained by individual differences in attention regulation and body awareness rankings. CONCLUSION: In patients with Crohn's disease, anti-TNFα administration reduces visceral sensitivity and improves implicit cognitive-affective biases linked to alterations in limbic (amygdala) function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a greater increase in AB toward self-referential positive vs. negative words and improvement of affective-cognitive and somatic depressive symptoms was observed after completion of anti-TNF-α therapy in patients with inflammatory bowel disease (Gray et al., 2018).”
From The interplay between stress, inflammation, and emotional attention: relevance for depression (2019) · cites this paper as Gray et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Measuring individual differences in implicit cognition: the implicit association test
Greenwald, A. G., McGhee, D. E., & Schwartz, J. L. K. (1998) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.74.6.1464 · Cited by 9,210 · cited 1×
“The Implicit Associations Test (IAT), first developed by Greenwald et al. (1998), allows investigation of how strongly one’s self-concept is associated to positive or negative attributes, compared to their association strength to others [35, 36].”
BackgroundHow do you feel? Interoception: The sense of the physiological condition of the body
Craig, A. D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn894 · Cited by 6,006
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Depression: Causes and treatment
(1973) · Behavior Therapy · doi:10.1016/s0005-7894(73)80054-1 · Cited by 3,152
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
Frackowiak, R. S. J. (1997) · Cited by 1,795
Snyder, H. R. (2013) · Psychological Bulletin · doi:10.1037/a0028727 · Cited by 1,667
A unified theory of implicit attitudes, stereotypes, self-esteem, and self-concept.
Greenwald, A. G., Banaji, M. R., Rudman, L. A., Farnham, S. D., Nosek, B. A., & Mellott, D. S. (2002) · Psychological Review · doi:10.1037/0033-295x.109.1.3 · Cited by 1,559
The multidimensional assessment of interoceptive awareness (MAIA)
Mehling, W. E., Price, C., Daubenmier, J. J., Acree, M., Bartmess, E., & Stewart, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048230 · Cited by 1,429
Thinking and Depression: I. Idiosyncratic Content and Cognitive Distortions
BECK, A. T. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720160014002 · Cited by 1,308
A new measure of health status for clinical trials in inflammatory bowel disease
Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., & Tompkins, C. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90905-0 · Cited by 1,298
Visceral influences on brain and behavior
Critchley, H. D., & Harrison, N. A. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.008 · Cited by 1,177
Performance on Indirect Measures of Race Evaluation Predicts Amygdala Activation
Phelps, E. A., O'Connor, K. J., Cunningham, W. A., Funayama, E. S., Gatenby, J. C., Gore, J. C., & Banaji, M. R. (2000) · Journal of Cognitive Neuroscience · doi:10.1162/089892900562552 · Cited by 1,001
Thinking and Depression: II. Theory and Therapy
BECK, A. T. (1964) · Archives of General Psychiatry · doi:10.1001/archpsyc.1964.01720240015003 · Cited by 820
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
DʼHaens, G., Ferrante, M., Vermeire, S., Baert, F., Noman, M., Moortgat, L., Geens, P., Iwens, D., Aerden, I., Van Assche, G., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22917 · Cited by 816 · cited 1×
“Interestingly, despite all patients reporting only minimal gastrointestinal symptoms and scoring below 150 on the CDAI, calprotectin levels reveal significant inflammation in 6/9 patients (adopting the conservative threshold published by D’Haens et al., 2012 of>250 μg/g [20]).”
BackgroundHarrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.015 · Cited by 756
Self-citationCytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Dantzer, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.040 · Cited by 743
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
Depression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561
Interoception: The Inside Story—A Model for Psychosomatic Processes
Cameron, O. G. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200109000-00001 · Cited by 535
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Optimizing anti-TNF treatment in inflammatory bowel disease
Rutgeerts, P., van Assche, G., & Vermeire, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.070 · Cited by 429
Eisenberger, N. I., Inagaki, T. K., Mashal, N. M., & Irwin, M. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.12.009 · Cited by 413
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
Hess, A., Axmann, R., Rech, J., Finzel, S., Heindl, C., Kreitz, S., Sergeeva, M., Saake, M., Garcia, M., Kollias, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011774108 · Cited by 356
Neural Origins of Human Sickness in Interoceptive Responses to Inflammation
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., Dolan, R. J., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.007 · Cited by 345
Self-citationDepressive realism: a meta-analytic review
Moore, M. T., & Fresco, D. M. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.05.004 · Cited by 291
Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease
Williet, N., Sandborn, W. J., & Peyrin–Biroulet, L. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.016 · Cited by 260
PERSOONS, P., VERMEIRE, S., DEMYTTENAERE, K., FISCHLER, B., VANDENBERGHE, J., VAN OUDENHOVE, L., PIERIK, M., HLAVATY, T., VAN ASSCHE, G., NOMAN, M., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02535.x · Cited by 253
Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes
Hughes, P. A., Harrington, A. M., Castro, J., Liebregts, T., Adam, B., Grasby, D. J., Isaacs, N. J., Maldeniya, L., Martin, C. M., Persson, J., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301856 · Cited by 197
Self-citationMartin-Subero, M., Anderson, G., Kanchanatawan, B., Berk, M., & Maes, M. (2016) · CNS Spectrums · doi:10.1017/s1092852915000449 · Cited by 196
The neural basis of implicit moral attitude—An IAT study using event-related fMRI
Luo, Q., Nakic, M., Wheatley, T., Richell, R., Martin, A., & Blair, R. J. R. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.11.005 · Cited by 191
A neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards
Harrison, N. A., Voon, V., Cercignani, M., Cooper, E. A., Pessiglione, M., & Critchley, H. D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.018 · Cited by 185
Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review
Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181
Neural correlates of automatic beliefs about gender and race
Knutson, K. M., Mah, L., Manly, C. F., & Grafman, J. (2007) · Human Brain Mapping · doi:10.1002/hbm.20320 · Cited by 169
af Björkesten, C.-G., Nieminen, U., Turunen, U., Arkkila, P., Sipponen, T., & Färkkilä, M. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.660542 · Cited by 153
Fractalkine mediates inflammatory pain through activation of satellite glial cells
de Souza, G. R., Talbot, J., Lotufo, C. M. D. C., Cunha, F. Q., Cunha, T. M., & Ferreira, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307445110 · Cited by 146
Bortolato, B., F. Carvalho, A., K. Soczynska, J., I. Perini, G., & S. McIntyre, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630171433 · Cited by 142
Bennebroek Evertsz', F., Thijssens, N. A. M., Stokkers, P. C. F., Grootenhuis, M. A., Bockting, C. L. H., Nieuwkerk, P. T., & Sprangers, M. A. G. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.07.006 · Cited by 131
Shestyuk, A. Y., & Deldin, P. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.06091444 · Cited by 112
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD
Molander, P., Sipponen, T., Kemppainen, H., Jussila, A., Blomster, T., Koskela, R., Nissinen, M., Rautiainen, H., Kuisma, J., Kolho, K.-L., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.10.018 · Cited by 110
Psychological stress and depression: risk factors for IBD
Bernstein, C. N. (2016) · Digestive Diseases · doi:10.1159/000442929 · Cited by 107
Haag, S., Senf, W., Tagay, S., Langkafel, M., Braun-Lang, U., Pietsch, A. P., Heuft, G., Talley, N. J., & Holtmann, G. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03277.x · Cited by 99
Self-citationDadsetan, S., Balzano, T., Forteza, J., Cabrera-Pastor, A., Taoro-Gonzalez, L., Hernandez-Rabaza, V., Gil-Perotín, S., Cubas-Núñez, L., García-Verdugo, J.-M., Agusti, A., et al. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00106 · Cited by 93
Feldman, S. R., Gottlieb, A. B., Bala, M., Wu, Y., Eisenberg, D., Guzzo, C., Li, S., Dooley, L. T., & Menter, A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08727.x · Cited by 86
Haag, S., Talley, N. J., & Holtmann, G. (2004) · Gut · doi:10.1136/gut.2003.030049 · Cited by 77
Self-citationHorst, S., Chao, A., Rosen, M., Nohl, A., Duley, C., Wagnon, J. H., Beaulieu, D. B., Taylor, W., Gaines, L., & Schwartz, D. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3375-0 · Cited by 75
Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data
Bojic, D., Bodger, K., & Travis, S. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw187 · Cited by 60
Mikocka‐Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J. M., & Holtmann, G. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05245.x · Cited by 56
Self-citationHughes, P. A., Moretta, M., Lim, A., Grasby, D. J., Bird, D., Brierley, S. M., Liebregts, T., Adam, B., Ashley Blackshaw, L., Holtmann, G., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.001 · Cited by 56
Self-citationNeural Patterns of the Implicit Association Test
Healy, G. F., Boran, L., & Smeaton, A. F. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00605 · Cited by 54
Haag, S., Senf, W., Tagay, S., Heuft, G., Gerken, G., Talley, N. J., & Holtmann, G. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01415.x · Cited by 51
Self-citationBeigel, F., Deml, M., Schnitzler, F., Breiteneicher, S., Göke, B., Ochsenkühn, T., & Brand, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099293 · Cited by 31
Heß, A., Roesch, J., Saake, M., Sergeeva, M., Hirschmann, S., Neumann, H., Dörfler, A., Neurath, M. F., & Atreya, R. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.063 · Cited by 29
Cadahía, V., García-Carbonero, A., Vivas, S., Fuentes, D., Niño, P., Rebollo, P., & Rodrigo, L. (2004) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082004000600002 · Cited by 24
Miwa, Y., Nishimi, A., Nishimi, S., Saito, M., Tokunaga, T., Yanai, R., Takahashi, R., Wakabayashi, K., Kasama, T., & Hosaka, M. (2014) · European Journal of Rheumatology · doi:10.5152/eurjrheumatol.2014.140074 · Cited by 10
5. Gastrointestinal Motility Dysfunction and Viscerosensory Dysfunction in Patients with FGID
Manabe, N., Hata, J., & Haruma, K. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.32 · Cited by 1
Research works printed but not linked: 1
- GT Holtmann, 1996, Comparison of gastric mechanosensory thresholds and maximal tolerance of a liquid meal, Gastroenterology, 110, A680
Cited by
Chen, L.-M., Bao, C.-H., Wu, Y., Liang, S.-H., Wang, D., Wu, L.-Y., Huang, Y., Liu, H.-R., & Wu, H.-G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02175-2 · Cited by 227
Labanski, A., Langhorst, J., Engler, H., & Elsenbruch, S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104501 · Cited by 200
The interplay between stress, inflammation, and emotional attention: relevance for depression
Maydych, V. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00384 · Cited by 193
“negative words and improvement of affectivecognitive and somatic depressive symptoms was observed after completion of anti-TNF-α therapy in patients with inflammatory bowel disease (Gray et al., 2018).”
BackgroundLee, K.-E., Kim, J.-K., Han, S.-K., Lee, D. Y., Lee, H.-J., Yim, S.-V., & Kim, D.-H. (2020) · Microbiome · doi:10.1186/s40168-020-00881-2 · Cited by 188
Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
Metadata
- Authors
- Gray, M. A., Chao, C.-Y., Staudacher, H. M., Kolosky, N. A., Talley, N. J., & Holtmann, G.
- Affiliations
- Translational Research Institute (AU)
- Princess Alexandra Hospital (AU)
- University of Newcastle Australia (AU)
- Corresponding author
- Gray, Marcus A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-03-08
- Volume
- 13
- Issue
- 3
- Pages
- e0193542
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5843226
- OpenAlex
- W2794008189
- Cited by
- 63
- References
- 60
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 3 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 6 · 2018: 1
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- inflammatory bowel disease, Crohn's disease, anti-TNF therapy, adalimumab, infliximab, visceral hypersensitivity, cognitive biases, depression, anxiety, amygdala, prefrontal cortex, posterior cingulate cortex, body awareness, attentional control
- MeSH terms
- Adalimumab, Infliximab, Adolescent, Adult, Affect, Anti-Inflammatory Agents, Brain, Brain Mapping, Cognition, Crohn Disease, Female, Gastrointestinal Agents, Humans, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Random Allocation, Satiation, Tumor Necrosis Factor-alpha, Visceral Afferents, Young Adult, Diagnostic Self Evaluation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.